[Featured Stock] Baeksuo Naturalendotech Shows Strong Performance for 3rd Day After Trading Resumption

Baeksuo

[Asia Economy Reporter Ji-hwan Park] Natural Endotech, famous for the Baeksuo controversy, has been on a sharp rise for three consecutive trading days since resuming trading.

As of 9:47 a.m. on the 8th, Natural Endotech is trading at 10,550 KRW on the KOSDAQ market, up 23.83% (2,030 KRW) from the previous trading day.

Natural Endotech recorded the daily price limit on the first day of resumed trading on the 6th and continued the price limit streak on the 7th.

The KOSDAQ Market Headquarters of the Korea Exchange held a corporate review committee on the 3rd and decided to maintain Natural Endotech's listing. Natural Endotech had been suspended from trading since February 15.

Natural Endotech is a company specializing in health functional foods. In 2015, its performance deteriorated due to a controversy over fake Baeksuo raw materials, which were known to be effective for female menopause, resulting in four consecutive years of losses. Subsequently, it was designated as a management item and faced the risk of delisting until recently.

This content was produced with the assistance of AI translation services.